Industry News
Existing leukemia drug brings new hope in fighting aggressive breast cancer
May 02, 2014
A drug used to treat leukemia patients shows promise in fighting triple-negative breast cancer, a particularly aggressive subtype often affecting African-American women, researchers at the... Read More
Study finds lymph node ultrasounds more accurate in obese breast cancer patients
May 02, 2014
Mayo Clinic research into whether ultrasounds to detect breast cancer in underarm lymph nodes are less effective in obese women has produced a surprising finding. Read More
Radiation and chemotherapy damage control
May 02, 2014
Researchers at the University of California, San Diego School of Medicine report that a protein called beta-catenin plays a critical, and previously unappreciated, role in promoting recovery of... Read More
Up to 40% of annual premature deaths in the US 'are preventable'
May 02, 2014
Between 20-40% of deaths below the age of 80 - from the five leading causes of death in the US - are due to modifiable risk factors that could be prevented, claim the CDC. Read More
First study to address the value of 3-dimensional genome organization in the classification of leukemia
May 02, 2014
To solve a puzzle, you need to recognize shapes, patterns and a particular kind of order. Read More
Hematology-2014, September 29-October 01, 2014, Baltimore
May 01, 2014
Novel therapeutics for blood disorders: A New hope for Patients suffering from severe Blood DisordersHematology-2014 is an endeavor from OMICS Group to identify the novel therapeutics for... Read More
New model can predict therapy outcomes in prostate cancer with bone metastasis
May 01, 2014
A new computational model that simulates bone metastasis of prostate cancer has the potential to rapidly assess experimental therapy outcomes and help develop personalized medicine for patients... Read More
Oncogenex announces top-line survival results of Phase 3 SYNERGY trial evaluating custirsen for metastatic castrate-resistant prostate cancer
May 01, 2014
OncoGenex Pharmaceuticals, Inc. has announced results from the Phase 3 SYNERGY trial. Read More
Research letter examines UV nail salon lamps and risk of skin cancer
May 01, 2014
Using higher-wattage ultra violet (UV) lamps at nail salons to dry and cure polish was associated with more UV-A radiation being emitted, but the brief exposure after a manicure would require... Read More
FDA approves Zykadia for late-stage lung cancer
May 01, 2014
The U.S. Food and Drug Administration today granted accelerated approval to Zykadia (ceritinib) for patients with a certain type of late-stage (metastatic) non-small cell lung cancer (NSCLC). Read More
Previous Page Next Page